• Exchange: Soc.Bol SIBE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GRF:SM

30.7750 EUR 0.2750 0.90%

As of 04:09:24 ET on 10/22/2014.

Snapshot for Grifols SA (GRF)

Open: 30.7150 Day's Range: 30.5600 - 30.9500 Volume: 188,749
Previous Close: 30.5000 52wk Range: 27.9100 - 42.5300 1-Yr Rtn: +6.33%

Stock Chart for GRF

No chart data available.
  • GRF:SM 30.7600
  • 1D
  • 1M
  • 1Y
30.5000
Interactive GRF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GRF

Current P/E Ratio (ttm) 27.3840
Estimated P/E(12/2014) 17.9714
Relative P/E vs. IBEX 1.3642
Earnings Per Share (EUR) (ttm) 1.1240
Est. EPS (EUR) (12/2014) 1.7130
Est. PEG Ratio 0.9566
Market Cap (M EUR) 9,947.51
Shares Outstanding (M) 213.06
30 Day Average Volume 1,185,106
Price/Book (mrq) 4.7424
Price/Sale (ttm) 3.5340
Dividend Indicated Gross Yield 0.81%
Cash Dividend (EUR) 0.1975
Dividend Ex-Date
5 Year Dividend Growth -1.58%
Next Earnings Announcement 11/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GRF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GRF

Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, Enteral nutrition, diagnostic systems, and medical materials.

Victor Grifols RouraChairman/CEORamon Riera RocaExec VP/Pres:Global Commercial
Alfredo Arroyo GuerraVP/CFOCarlos Roura FernandezVP/Pres:Global Industrial
More Company Profile & Key Executives for GRF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil